PL348049A1 - Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications - Google Patents
Pyridinium derivatives for the treatment of diabetic and aging−related vascular complicationsInfo
- Publication number
- PL348049A1 PL348049A1 PL99348049A PL34804999A PL348049A1 PL 348049 A1 PL348049 A1 PL 348049A1 PL 99348049 A PL99348049 A PL 99348049A PL 34804999 A PL34804999 A PL 34804999A PL 348049 A1 PL348049 A1 PL 348049A1
- Authority
- PL
- Poland
- Prior art keywords
- diabetic
- aging
- treatment
- vascular complications
- related vascular
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN827CA1999 | 1999-10-06 | ||
| PCT/IB1999/001687 WO2001025209A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL348049A1 true PL348049A1 (en) | 2002-05-06 |
Family
ID=11084921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99348049A PL348049A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1220843A1 (en) |
| JP (1) | JP2003511370A (en) |
| CN (1) | CN1329597A (en) |
| AU (1) | AU5994499A (en) |
| BR (1) | BR9915962A (en) |
| CA (1) | CA2351075A1 (en) |
| CZ (1) | CZ20011808A3 (en) |
| HK (1) | HK1044336A1 (en) |
| HU (1) | HUP0301687A2 (en) |
| MX (1) | MXPA02003496A (en) |
| PL (1) | PL348049A1 (en) |
| WO (1) | WO2001025209A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067851A2 (en) * | 2000-12-29 | 2002-09-06 | Alteon, Inc. | Method for treating fibrotic diseases or other indications iiic |
| CZ303214B6 (en) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridinium compound, process of its preparation, its use, pharmaceutical composition in which it is comprised and use thereof |
| DK1243581T3 (en) * | 2001-03-21 | 2005-10-31 | Torrent Pharmaceuticals Ltd | Pyridinium compounds for the treatment of AGE-related diseases |
| SI1373263T1 (en) * | 2001-04-05 | 2005-04-30 | Torrent Pharmaceuticals Ltd | Heterocyclic compounds for aging-related and diabetic vascular complications |
| HUP0104831A2 (en) * | 2001-10-19 | 2003-08-28 | Torrent Pharmaceuticals Ltd. | Composition and method for use of pyridinium derivatives in therapeutic applications |
| GB0328314D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Bath | Therapeutics |
| WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
| JP2009155315A (en) * | 2007-12-26 | 2009-07-16 | Fujiyakuhin Co Ltd | Injection product |
| KR20120018185A (en) * | 2009-05-07 | 2012-02-29 | 토렌트 파마슈티칼스 리미티드 | Piperidine Derivatives Useful for the Treatment of Diabetes |
| ES2899694T3 (en) * | 2012-10-05 | 2022-03-14 | Sphaera Pharma Pte Ltd | Novel compounds, their synthesis and their uses |
| WO2016162785A1 (en) * | 2015-04-08 | 2016-10-13 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH335521A (en) * | 1955-06-02 | 1959-01-15 | Cilag Ag | Process for the preparation of new quaternary salts |
| US3318787A (en) * | 1964-02-07 | 1967-05-09 | Udylite Corp | Electrodeposition of zinc |
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| JPS5936247B2 (en) * | 1977-04-20 | 1984-09-03 | ティーディーケイ株式会社 | electrical display device |
| JPS55138742A (en) * | 1979-04-17 | 1980-10-29 | Fuji Photo Film Co Ltd | Silver halide emulsion developing method |
| JPH0253759A (en) * | 1988-08-18 | 1990-02-22 | Hamari Yakuhin Kogyo Kk | Novel quaternary ammonium compound |
| DD275872A1 (en) * | 1988-09-27 | 1990-02-07 | Univ Dresden Tech | PROCESS FOR PREPARING 5H-PYRIDO [1 ', 2': 1,2] IMIDAZO [5,4-C] CHINOLIN-6-ONEN |
| WO1996022095A2 (en) * | 1995-01-18 | 1996-07-25 | Alteon Inc. | Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| WO1998044925A1 (en) * | 1997-04-04 | 1998-10-15 | Smithkline Beecham Corporation | Calcilytic compounds |
-
1999
- 1999-10-15 CZ CZ20011808A patent/CZ20011808A3/en unknown
- 1999-10-15 MX MXPA02003496A patent/MXPA02003496A/en unknown
- 1999-10-15 HU HU0301687A patent/HUP0301687A2/en unknown
- 1999-10-15 HK HK02105890.8A patent/HK1044336A1/en unknown
- 1999-10-15 AU AU59944/99A patent/AU5994499A/en not_active Abandoned
- 1999-10-15 PL PL99348049A patent/PL348049A1/en not_active Application Discontinuation
- 1999-10-15 BR BR9915962-7A patent/BR9915962A/en not_active IP Right Cessation
- 1999-10-15 CA CA002351075A patent/CA2351075A1/en not_active Abandoned
- 1999-10-15 CN CN99814055A patent/CN1329597A/en active Pending
- 1999-10-15 WO PCT/IB1999/001687 patent/WO2001025209A1/en not_active Application Discontinuation
- 1999-10-15 EP EP99974071A patent/EP1220843A1/en not_active Withdrawn
- 1999-10-15 JP JP2001528155A patent/JP2003511370A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2351075A1 (en) | 2001-04-12 |
| AU5994499A (en) | 2001-05-10 |
| HUP0301687A2 (en) | 2003-08-28 |
| CZ20011808A3 (en) | 2001-08-15 |
| HK1044336A1 (en) | 2002-10-18 |
| EP1220843A1 (en) | 2002-07-10 |
| MXPA02003496A (en) | 2005-06-20 |
| WO2001025209A1 (en) | 2001-04-12 |
| CN1329597A (en) | 2002-01-02 |
| BR9915962A (en) | 2003-01-07 |
| JP2003511370A (en) | 2003-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1781901A (en) | Expandable venous cannula and method of use | |
| AU5056300A (en) | Devices and compounds for treating arterial restenosis | |
| AU5788300A (en) | Medical treatment method and kit | |
| PT1231887E (en) | Method and composition for the treatment of scars | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| MXPA01009415A (en) | Ascorbic acid composition and method for treatment of aging or damaged skin. | |
| AU4717301A (en) | Catheter assembly and method of use | |
| AU5774100A (en) | Method and apparatus for the noninvasive determination of arterial blood pressure | |
| AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
| AU2188700A (en) | Intravascular cardiac assist device and method | |
| HUP0104116A3 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
| EP1089731A4 (en) | Compositions and methods for treating elevated blood cholesterol | |
| EP1305018A4 (en) | Method and compositions for prevention and/or treatment of diabetes and glucose modulation | |
| PL348049A1 (en) | Pyridinium derivatives for the treatment of diabetic and aging−related vascular complications | |
| AU2001244461A1 (en) | Venous line catheter and method of operating the same | |
| EP1089732A4 (en) | Compositions and methods for treating elevated blood cholesterol | |
| HUP0200738A3 (en) | Method of the treatment of incontinence | |
| AU1794801A (en) | Method for treatment and prevention of physiological shock | |
| AU1321101A (en) | Cholesterol lowering and blood lipids lowering composition | |
| AU2420101A (en) | Method and composition for the treatment of pain | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU6648200A (en) | Method and composition for preventing or treating adverse physiological effects associated with cardiac disease | |
| HUP0300043A3 (en) | Method and composition for the treatment of pain | |
| IL150208A0 (en) | Compound and method for the treatment of pain | |
| AU2420201A (en) | Compounds and methods for the treatment of pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |